How it has done since the IPO
Closing prices since listing: 26 Oct ₹257.25, 27 Oct ₹253.85, 28 Oct ₹270.05, 29 Oct ₹260.80, 30 Oct ₹264.50, 2 Nov ₹266.75, 3 Nov ₹268.50, 4 Nov ₹262.35, 5 Nov ₹259.90, 6 Nov ₹251.05.
| Listing day | 25 Jun 2025 |
| Open / high / low / close | ₹132.50 / ₹135.85 / ₹125.90 / ₹126.20 |
| Shares traded on NSE | 32,12,400 |
| Market value at the listing-day close | ₹292 cr |
Influx Healthtech share price, live chart and technicals →
The IPO's journey
Anchor17 Jun
Opens18 Jun
Closes20 Jun
Allotment23 Jun
In demat24 Jun
Listing25 Jun
Lock-in 50%22 Jul
Lock-in rest20 Sept
Subscription
Shares offered and bid, by group
| Investor category | Shares bid for |
|---|
| Institutions (QIB) | 15,98,18,400 |
| HNI / NII | 41,88,78,000 |
| Retail | 23,88,42,000 |
| Total | 81,75,38,400 |
NSE does not publish the shares offered to each category for this issue, so times subscribed cannot be shown. NSE and BSE bids together, as of 20 Jun 2025 19:00.
Who the issue was for
Bids by price
Top price ₹96 81.98%Cut-off 17.98%Lower prices 0.0%
Applications from individual investors
1,99,035 applications in the individual investors' category.
NSE does not publish the shares set aside for this category for SME issues, so the chance of allotment cannot be worked out exactly. Winners are picked by lottery.
Lot size by investor type
| Application | Lots | Shares | Amount |
|---|
| Individual investor (minimum) | 1 | 1,200 | ₹1,15,200 |
| HNI (minimum) | 2 | 2,400 | ₹2,30,400 |
At ₹96 a share. In SME IPOs individuals must bid for at least 1 lots.
Anchor investors
| Anchor bid date | 17 Jun 2025 |
| Anchor shares | 17,36,400 |
| Raised from anchors | ₹16.67 cr |
| Lock-in ends for the first 50% (30 days) | 22 Jul 2025 |
| Lock-in ends for the remaining 50% (90 days) | 20 Sept 2025 |
Anchor investors are large funds that buy the day before the IPO opens. SEBI locks in half their shares for 30 days from the allotment and the rest for 90 days; they can sell from the next trading day. Traders watch these dates because extra selling can come in.
Financials and valuation
| At issue price |
|---|
| Market value | ₹222 cr |
| P/E (last 12 months' profit) | 9.8 |
| Revenue, last 12 months | ₹165 cr |
| Profit, last 12 months | ₹23 cr |
| Return on equity | – |
| Debt to equity | – |
From results the company filed with NSE (latest period to 30 Sept 2026). Twelve-month figures need four quarters of results, so they fill in over the first year after listing.
Other recent IPOs: Pharmaceuticals